544445 — Asston Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.42bn
- IN₹1.46bn
- IN₹254.69m
Annual cashflow statement for Asston Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | R2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 14.1 | 18.2 | 50.2 | 45.9 |
| Depreciation | ||||
| Non-Cash Items | 10.6 | 14.6 | 10.8 | 4.76 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -28.2 | -71.2 | -61.6 | -156 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -3.16 | -38 | -0.253 | -102 |
| Capital Expenditures | -2.51 | -0.103 | — | -101 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -6.61 | 0.049 | 7.3 | 1.55 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -9.12 | -0.054 | 7.3 | -99.1 |
| Financing Cash Flow Items | -7.21 | -9.33 | -9.5 | -6.33 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 12.1 | 36.9 | -5.13 | 212 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.131 | -1.17 | 1.93 | 10.9 |